New funding for the Centre
CeFH has been awarded 3 new research projects
Three research applications involving researchers from the Centre were recently approved.
Research project: The intrauterine redox state and telomere length in the newborn.
Project manager: Håkon Gjessing, in collaboration with Astanand Jusgessur and others.
Funded by: The Research Council of Norway, FRIMEDBIO program.
The project will examine (1) the association between newborn's leukocyte telomere length and mitochondrial genotypes, and (2) associations between newborn's leukocyte telomere length and maternal smoking during pregnancy.
Research project: Social, demographic and health dimensions of technology-induced job loss.
Project manager: Vegard Skirbekk
Funded by: The Research Council of Norway, VAM program.
The project will study Norwegian population registries and surveys on occupation and firm data, education, cognitive test performance, personality, coping, health, intergenerational data, social isolation, physiological and mental health trajectories. We will study how these factors relate to how individuals respond in terms of demographic, social and health outcomes, including quality of life, re-employment, disease incidence, training and demographic outcomes (e.g., partnership stability, childbearing, internal migration).
Research project: Accelerated development of therapies for age-related diseases through a more precise measurement of biological age in humans.
Project manager: Age Labs
Researchers from the Centre involved in the project:
Funded by: The Research Council of Norway, BIA program.
Researchers at the Centre are partners in this application aiming to develop a novel biomarker that will predict all-cause mortality risk and risk of developing specific age-related diseases.